(Q36770311)

16 August 2017

Inhibition of cell-mediated immunity by the histone deacetylase inhibitor vorinostat: implications for therapy of cutaneous T-cell lymphoma (English)

1 reference

16 August 2017

Sasha Stephen

1

1 reference

16 August 2017

Kelly A Morrissey

2

1 reference

16 August 2017

Bernice M Benoit

3

1 reference

16 August 2017

Ellen J Kim

4

1 reference

16 August 2017

Carmela C Vittorio

5

1 reference

16 August 2017

Sunita D Nasta

6

1 reference

16 August 2017

Louise C Showe

7

1 reference

16 August 2017

Maria Wysocka

8

1 reference

16 August 2017

Alain H Rook

9

1 reference

16 August 2017

21 December 2011

1 reference

American Journal of Hematology

16 August 2017

1 reference

16 August 2017

87

1 reference

16 August 2017

2

1 reference

16 August 2017

226-228

1 reference

Reactivation of DNA viruses in association with histone deacetylase inhibitor therapy: a case series report

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3627830

Histone deacetylase inhibitors: molecular mechanisms of action

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3627830

The histone deacetylase inhibitor ITF2357 reduces production of pro-inflammatory cytokines in vitro and systemic inflammation in vivo

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3627830

Selective induction of apoptosis by histone deacetylase inhibitor SAHA in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3627830

Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3627830

Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3627830

Reciprocal activating interaction between natural killer cells and dendritic cells

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3627830

Vorinostat for the treatment of bullous pemphigoid in the setting of advanced, refractory cutaneous T-cell lymphoma

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3627830

Deacetylase inhibition promotes the generation and function of regulatory T cells.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3627830

IL-12 reverses cytokine and immune abnormalities in Sezary syndrome

5 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22189940

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Histone hyperacetylation is associated with amelioration of experimental colitis in mice

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22189940

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Synthetic imidazoquinolines potently and broadly activate the cellular immune response of patients with cutaneous T-cell lymphoma: synergy with interferon-gamma enhances production of interleukin-12

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22189940

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/AJH.22231

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

22189940

1 reference